Eli Lilly stock fell on Tuesday after Novo Nordisk, its rival in diabetes and weight-loss drugs, secured regulatory approval ...
The cybersecurity landscape in 2026 presents unprecedented challenges for organizations across all industries. With ...
The Railroad Commission will determine whether the project meets state regulatory requirements following the prehearing.
Throughout 2025, CancerVax achieved substantial scientific progress, expanded its leadership and intellectual property portfolio, and advanced the development of its AI-engineered "Smart mRNA" and ...
Ulta, which stocks drugstore beauty brands like Maybelline as well as high-end brands, has had in-store hair salons since its ...
The Punch on MSN
FG reactivates terrorism charges against Bello Turji, associates
The Nigerian government has reopened its terrorism case against notorious kingpin Bello Turji and his associates. Learn about ...
Edmonton Journal on MSNOpinion
Tuesday's letters: Column unfair to King Thunderbird critics
Keith Gerein trivializes and distorts neighbourhood opposition to the King Thunderbird Centre. Gerein’s distorted account is ...
Shariot could be hived off into a JV with potential investors; group plans to begin repaying debts in January as its ...
Wegovy pill showed a mean weight loss of 16.6% in the OASIS 4 trial1Wegovy pill is indicated to reduce excess body weight and maintain weight reduction long-term and to reduce the risk of major advers ...
The 2025 Seltos is powered by the same Smartstream G1.5 T-GDi (turbo-petrol) engine as the outgoing Kia Seltos and Carens ...
Unlike the linear sprints of Agile, CAIL is a "contracts-first" framework designed to tame the probabilistic nature of AI ...
Shares rose 5% for Novo Nordisk on the approval of oral Wegovy as it looks to ease market pressures with a significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results